Concepedia

Author

Kiyoharu Shirakawa

Mochida Pharmaceutical (Japan)

Also Known As

KIYOHARU SHIRAKAWA, Kiyoharu SHIRAKAWA, Kiyoharu Shirakawa

24

Publications

390

Citations

12

H-Index

42

Concepts

All Affiliations

Mochida Pharmaceutical (Japan)University of EdinburghFujisawa City HospitalThe University of Osaka
KS

About

Kiyoharu Shirakawa is an author at Mochida Pharmaceutical (Japan) specializing in medicine, pharmacology, and neuropharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

9

9

160

2

Social Sciences

4

4

68

3

Engineering

1

1

15

4

Health Sciences

1

1

10

5

Natural Sciences

1

1

15

Kiyoharu Shirakawa

×

14

Publications

352

Citations

12

H-Index

YearCitations

Pharmacological Characterization of FR194921, a New Potent, Selective, and Orally Active Antagonist for Central Adenosine A1 Receptors

Takuya Maemoto, Miho Tada, Takuma Mihara,

Journal of Pharmacological Sciences

2004

78

The configuration and conformation of the arabinose moiety in platycodins, saponins isolated from , and mi-saponins from based on carbon-13 and hydrogen-1 nmr spectroscopic evidence: The total structures of the saponins

Hiroshi Ishii, Isao Kitagawa, Kazuhiro Matsushita,

Tetrahedron Letters

1981

56

Studies on Cerebral Protective Agents. IX. Synthesis of Novel 1,2,3,4-Tetrahydroisoquinolines as N-Methyl-D-aspartate Antagonists.

Mitsuru Ohkubo, Atsushi Kuno, Kiyotaka Katsuta,

Chemical and Pharmaceutical Bulletin

1996

33

The Neuroprotective Effect of the Novel Noncompetitive NMDA Antagonist, FR115427 in Focal Cerebral Ischemia in Rats

Kiyotaka Katsuta, Hajime Nakanishi, Kiyoharu Shirakawa,

Journal of Cerebral Blood Flow & Metabolism

1995

32

Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine

Miho Tada, Kiyoharu Shirakawa, Nobuya Matsuoka,

Psychopharmacology

2004

24

Neurochemical and electrophysiological studies on FR115427, a novel non-competitive NMDA receptor antagonist

J. P. Hodgkiss, Helen J. Sherriffs, David A. Cottrell,

European Journal of Pharmacology

1993

19

FK960, a novel potential anti-dementia drug, enhances high K+-evoked release of somatostatin from rat hippocampal slices

Tatsuo Inoue, Feng Wang, Akira Moriguchi,

Brain Research

2001

18

Effects of crude drugs on congestive edema.

Johji Yamahara, Yuko Takagi, TOKUNOSUKE SAWADA,

Chemical and Pharmaceutical Bulletin

1979

17

Chemical transformation of uronic acids leading to aminocyclitols. III. Syntheses of aminocyclitols and aminocyclitol-oligoglycosides from uronic acids and glucuronide-saponins by means of electrolytic decarboxylation.

Isao Kitagawa, Masayuki Yoshikawa, Toshiyuki Kamigauchi,

Chemical and Pharmaceutical Bulletin

1981

15

Characterisation of the binding of [3H]FR115427, a novel non-competitive NMDA receptor antagonist, to rat brain membranes

Helen J. Sherriffs, Kiyoharu Shirakawa, John Kelly,

European Journal of Pharmacology Molecular Pharmacology

1993

14

Page 1